Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2017097197) MOEXITECAN PHARMACEUTICAL COMPOSITION
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2017/097197 International Application No.: PCT/CN2016/108841
Publication Date: 15.06.2017 International Filing Date: 07.12.2016
IPC:
A61K 31/337 (2006.01) ,A61K 9/127 (2006.01) ,A61K 9/19 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
335
having oxygen as the only ring hetero atom, e.g. fungichromin
337
having four-membered rings, e.g. taxol
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
10
Dispersions; Emulsions
127
Liposomes
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
14
Particulate form, e.g. powders
19
lyophilised
Applicants:
正大天晴药业集团股份有限公司 CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. [CN/CN]; 中国江苏省连云港市 海州区郁州南路369号 No. 369 Yuzhou South Rd., Haizhou District Lianyungang, Jiangsu 222062, CN
Inventors:
张喜全 ZHANG, Xiquan; CN
董平 DONG, Ping; CN
张焕青 ZHANG, Huanqing; CN
程艳菊 CHENG, Yanju; CN
周浩 ZHOU, Hao; CN
蒋波 JIANG, Bo; CN
刘飞 LIU, Fei; CN
Agent:
北京英赛嘉华知识产权代理有限责任公司 INSIGHT INTELLECTUAL PROPERTY LIMITED; 中国北京市 海淀区知春路甲48号盈都大厦A座19A 19 A, Tower A, InDo Building No. 48A Zhichun Road, Haidian District Beijing 100098, CN
Priority Data:
201510896290.708.12.2015CN
Title (EN) MOEXITECAN PHARMACEUTICAL COMPOSITION
(FR) COMPOSITION PHARMACEUTIQUE DE MOEXITECAN
(ZH) 美西替康的药物组合物
Abstract:
(EN) Provided is a moeixitecan pharmaceutical composition comprising moexitecan, phospholipids or a mixture of phospholipids and cholesterol, and a lyoprotectant, wherein the weight ratio of the moexitecan, the phospholipids or a mixture of phospholipids and cholesterol, and the lyoprotectant is 1-5:10-400:10-100.
(FR) L'invention concerne une composition pharmaceutique de moexitecan comprenant du moexitecan, des phospholipides ou un mélange de phospholipides et de cholestérol, et un lyoprotecteur, le rapport pondéral du moexitecan, des phospholipides ou d’un mélange de phospholipides et de cholestérol, et du lyoprotecteur étant de 1 à 5 : 10 à 400 : 10 à 100.
(ZH) 美西替康的药物组合物,其包含美西替康、磷脂或磷脂与胆固醇的混合物和冻干保护剂,其中美西替康、磷脂或磷脂与胆固醇的混合物和冻干保护剂之间的重量比为1-5:10-400:10-100。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)
Also published as:
CN108289877